|
1
|
Bagaria SP, Gabriel E and Mann GN:
Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol.
117:62–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li Y, Wu G, Zhang Y, Yang W, Wang X, Duan
L, Niu L, Chen J, Zhou W, Liu J, et al: Development and validation
of a prognostic model to predict the prognosis of patients with
retroperitoneal liposarcoma: A large international population-based
cohort study. Front Oncol. 12:8578272022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muratori F, Frenos F, Bettini L, Matera D,
Mondanelli N, Scorianz M, Cuomo P, Scoccianti G, Beltrami G, Greto
D, et al: Liposarcoma: Clinico-pathological analysis, prognostic
factors and survival in a series of 307 patients treated at a
single institution. J Orthop Sci. 23:1038–1044. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salerno KE and Baldini EH: Role of
radiation therapy in retroperitoneal sarcoma. J Natl Compr Canc
Netw. 20:845–849. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Molina G, Hull MA, Chen YL, DeLaney TF, De
Amorim Bernstein K, Choy E, Cote G, Harmon DC, Mullen JT and Haynes
AB: Preoperative radiation therapy combined with radical surgical
resection is associated with a lower rate of local recurrence when
treating unifocal, primary retroperitoneal liposarcoma. J Surg
Oncol. 114:814–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lewis JJ, Leung D, Woodruff JM and Brennan
MF: Retroperitoneal soft-tissue sarcoma: Analysis of 500 patients
treated and followed at a single institution. Ann Surg.
228:355–365. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Neuhaus SJ, Barry P, Clark MA, Hayes AJ,
Fisher C and Thomas JM: Surgical management of primary and
recurrent retroperitoneal liposarcoma. Br J Surg. 92:246–252. 2015.
View Article : Google Scholar
|
|
8
|
Singer S, Antonescu CR, Riedel E and
Brennan MF: Histologic subtype and margin of resection predict
pattern of recurrence and survival for retroperitoneal liposarcoma.
Ann Surg. 238:358–371. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu YX, Liu JY, Liu JJ, Yan P, Tang B, Cui
YH, Zhao YL, Shi Y, Hao YX, Yu PW and Qian F: A retrospective,
single-center cohort study on 65 patients with primary
retroperitoneal liposarcoma. Oncol Lett. 15:1799–1810.
2018.PubMed/NCBI
|
|
10
|
Yan Y, Xia S, Teng D, Hu S, Li S, Wang Y,
Du X and Li R: Resection outcomes for primary and local recurrent
retroperitoneal liposarcoma patients. Ann Transl Med. 8:14502020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun P, Ma R, Liu G, Wang L, Chang H and Li
Y: Pathological prognostic factors of retroperitoneal liposarcoma:
Comprehensive clinicopathological analysis of 124 cases. Ann Transl
Med. 9:5742021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xue G, Wang Z, Li C, Lv A, Tian X, Wu J,
Qiu H and Hao C: A novel nomogram for predicting local
recurrence-free survival after surgical resection for
retroperitoneal liposarcoma from a Chinese tertiary cancer center.
Int J Clin Oncol. 26:145–153. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sánchez-Hidalgo JM, Rufián-Peña S,
Durán-Martínez M, Arjona-Sánchez Á, Salcedo-Leal I, Lopez-Cillero P
and Briceño-Delgado J: Risk factors of early recurrence in
retroperitoneal liposarcoma. Cir Esp (Engl Ed). 96:568–576. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gronchi A, Miah AB, Dei Tos AP, Abecassis
N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, et
al: Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS
clinical practice guidelines for diagnosis, treatment and
follow-up. Ann Oncol. 32:1348–1365. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nassif EF, Cope B, Traweek R, Witt RG,
Erstad DJ, Scally CP, Thirasastr P, Zarzour MA, Ludwig J, Benjamin
R, et al: Real-world use of palbociclib monotherapy in
retroperitoneal liposarcomas at a large volume sarcoma center. Int
J Cancer. 150:2012–2024. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhuang A, Wu Q, Tong H, Zhang Y and Lu W:
Development and validation of a nomogram for predicting
recurrence-free survival of surgical resected retroperitoneal
liposarcoma. Cancer Manag Res. 13:6633–6639. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao J, Liu J, Chen M, Liu W and He X:
Diagnosis and prognosis of retroperitoneal liposarcoma: A single
Asian center cohort of 57 cases. J Oncol. 2021:75940272021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spolverato G, Chiminazzo V, Lorenzoni G,
Fiore M, Radaelli S, Sanfilippo R, Sangalli C, Barisella M,
Callegaro D and Gronchi A: Oncological outcomes after major
vascular resections for primary retroperitoneal liposarcoma. Eur J
Surg Oncol. 47:3004–3010. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Littau MJ, Kulshrestha S, Bunn C, Agnew S,
Sweigert P, Luchette FA and Baker MS: The importance of the margin
of resection and radiotherapy in retroperitoneal liposarcoma. Am J
Surg. 221:554–560. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miao CL, Zhang LL, Tseng WW, Qiu FB, Lu
WQ, Dai YG, Rao XS, Li WJ, Zhang GK, Chen J, et al: A better
overall survival (OS) for total (ipsilateral) retroperitoneal
lipectomy than standard complete resection in patients with
retroperitoneal liposarcoma: A comparative multi-institutional
study. Ann Transl Med. 10:7852022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Naszai M, Kurjan A and Maughan TS: The
prognostic utility of pre-treatment neutrophil-to-lymphocyte-ratio
(NLR) in colorectal cancer: A systematic review and meta-analysis.
Cancer Med. 10:5983–5997. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guthrie GJK, Charles KA, Roxburgh CSD,
Horgan PG, McMillan DC and Clarke SJ: The systemic
inflammation-based neutrophil-lymphocyte ratio: Experience in
patients with cancer. Crit Rev Oncol Hematol. 88:218–230. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dehner CA, Hagemann IS and Chrisinger JSA:
Retroperitoneal dedifferentiated liposarcoma. Am J Clin Pathol.
156:920–925. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu W, Zou B, Tang M, Li X, Huang M, Chen
W and Miao C: Prediction of intraoperative bleeding and blood
transfusion in patients with recurrent retroperitoneal liposarcoma:
A retrospective study. Ann Transl Med. 10:9862022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ishii K, Yokoyama Y, Nishida Y, Koike H,
Yamada S, Kodera Y, Sassa N, Gotoh M and Nagino M: Characteristics
of primary and repeated recurrent retroperitoneal liposarcoma:
Outcomes after aggressive surgeries at a single institution. Jpn J
Clin Oncol. 50:1412–1418. 2020. View Article : Google Scholar : PubMed/NCBI
|
